Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 30,564 | 26,771 | 22,058 | 27,872 | 25,488 |
| Cost of Goods | 1,628 | 1,151 | 894 | 1,177 | 958 |
| Gross Profit | 28,936 | 25,620 | 21,164 | 26,695 | 24,530 |
| Operating Expenses | 22,637 | 23,600 | 19,785 | 26,207 | 21,255 |
| Operating Income | 6,925 | 2,171 | 2,273 | 665 | 4,233 |
| Other Income | 704 | 67 | 2,362 | 107 | -303 |
| Pre-tax Income | 7,629 | 2,238 | 4,635 | 772 | 3,930 |
| Income Tax | 1,693 | 662 | 901 | 203 | 1,074 |
| Net Income Continuous | 5,936 | 1,576 | 3,734 | 569 | 2,856 |
| Minority Interests | 2,326 | 1,134 | 1,036 | 668 | 1,732 |
| Net Income | $3,610 | $442 | $2,698 | $-99 | $1,124 |
| EPS Basic Total Ops | 0.04 | 0.00 | 0.03 | 0.00 | 0.01 |
| EPS Basic Continuous Ops | 0.07 | 0.02 | 0.04 | 0.00 | 0.03 |
| EPS Diluted Total Ops | 0.03 | 0.00 | 0.00 | N/A | 0.01 |
| EPS Diluted Continuous Ops | 0.06 | 0.02 | 0.04 | 0.01 | 0.03 |
| EPS Diluted Before Non-Recurring Items | 0.05 | 0.02 | 0.00 | 0.01 | 0.02 |
| EBITDA(a) | $7,576 | $2,812 | $2,808 | $1,165 | $4,678 |